08-09-2017 05:49 via articlefeeds.nasdaq.com

Why Intra-Cellular Therapies Is Surging Today

What happened Shares of Intra Cellular Therapies NASDAQ ITCI a clinical stage pharma company focused on diseases of the central nervous system jumped more than 17 as of 3 15 p m EDT on Thursday The bullish move was caused by the company s release of positive clinical
Read more »